Gene · 79001
Papers3,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients. | Br J Clin Pharmacol | 2024 | 37940132 | PubTator, text mining | PubMed |
| The cytotoxic potential of sinapic acid on luminal A breast cancer; a computational and experimental pharmacology approach. | J Biomol Struct Dyn | 2024 | 37904539 | PubTator, text mining | PubMed |
| In silico evaluation of pharmacokinetic parameters, delivery, distribution and anticoagulative effects of new 4,7-dihydroxycoumarin derivative. | J Biomol Struct Dyn | 2024 | 37545173 | PubTator, text mining | PubMed |
| Allergic and other adverse reactions to drugs used in anesthesia and surgery. | Anesthesiol Perioper Sci | 2023 | 40476920 | PubTator, text mining | PubMed |
| A Case of Unexplained Warfarin Resistance: A Case Report and Literature Review. | J Tehran Heart Cent | 2023 | 38680643 | PubTator, text mining | PubMed |
| Lipid Disorders and Cardiovascular Risk: A Comprehensive Analysis of Current Perspectives. | Cureus | 2023 | 38292957 | PubTator, text mining | PubMed |
| Thrombotic and Hemorrhagic Complications Following Left Ventricular Assist Device Placement: An Emphasis on Gastrointestinal Bleeding, Stroke, and Pump Thrombosis. | Cureus | 2023 | 38283491 | PubTator, text mining | PubMed |
| Current Evidence and Expert Opinion on Thromboprophylaxis After Total Knee and Hip Replacement. | Cureus | 2023 | 38274925 | PubTator, text mining | PubMed |
| The association between warfarin usage and international normalized ratio increase: systematic analysis of FDA Adverse Event Reporting System (FAERS). | J Cardiovasc Aging | 2023 | 38235056 | PubTator, text mining | PubMed |
| Review of Teratogenic Effects of Leflunomide, Accutane, Thalidomide, Warfarin, Tetracycline, and Angiotensin-Converting Enzyme Inhibitors. | Cureus | 2023 | 38222129 | PubTator, text mining | PubMed |
Amyloidogenic and Neuroinflammatory Molecular Pathways Are Contrasted Using Menaquinone 4 (MK4) and Reduced Menaquinone 7 (MK7R) in Association with Increased DNA Methylation in SK-N-BE Neuroblastoma Cell Line. | Cells | 2023 | 38201262 | PubTator, text mining | PubMed |
| Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 1. | Eur Cardiol | 2023 | 38174217 | PubTator, text mining | PubMed |
| Anticoagulant drugs for patients with atrial fibrillation on dialysis: a systematic analysis and network meta-analysis. | Front Pharmacol | 2023 | 38161701 | PubTator, text mining | PubMed |
| Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia. | J Clin Med | 2023 | 38137783 | PubTator, text mining | PubMed |
| Vitamin K and Calcium Chelation in Vascular Health. | Biomedicines | 2023 | 38137375 | PubTator, text mining | PubMed |
| Genetics in Ischemic Stroke: Current Perspectives and Future Directions. | J Cardiovasc Dev Dis | 2023 | 38132662 | PubTator, text mining | PubMed |
| Validation of bioanalytical method for quantification of Vitamin K2 (MK-4) in human plasma by high-performance liquid chromatography-ultraviolet. | J Adv Pharm Technol Res | 2023 | 38107456 | PubTator, text mining | PubMed |
| Machine learning models to predict the warfarin discharge dosage using clinical information of inpatients from South Korea. | Sci Rep | 2023 | 38105280 | PubTator, text mining | PubMed |
| Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis. | JACC Asia | 2023 | 38095004 | PubTator, text mining | PubMed |
| Menahydroquinone-4 may play a key role in regulating CCL5 expression induced by epidermal growth factor receptor inhibitors. | Sci Rep | 2023 | 38092882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79001/papers?page=9